Various drug classes have been identified that enhance insulin sensitivity in patients with prediabetes or diabetes mellitus, including biguanides, thiazolidinediones, GLP-1 receptor agonists, and SGLT2 inhibitors. The gene discussed is INS; the disease is prediabetes syndrome.